These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10442 related articles for article (PubMed ID: 15089040)

  • 1. (-)-Epigallocatechin-3-gallate and hinokitiol reduce melanin synthesis via decreased MITF production.
    Kim DS; Park SH; Kwon SB; Li K; Youn SW; Park KC
    Arch Pharm Res; 2004 Mar; 27(3):334-9. PubMed ID: 15089040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.
    Kim DS; Kim SY; Park SH; Choi YG; Kwon SB; Kim MK; Na JI; Youn SW; Park KC
    Biol Pharm Bull; 2005 Dec; 28(12):2216-9. PubMed ID: 16327152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of melanosomal proteins after hinokitiol treatment.
    Choi YG; Bae EJ; Kim DS; Park SH; Kwon SB; Na JI; Park KC
    J Dermatol Sci; 2006 Sep; 43(3):181-8. PubMed ID: 16781122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells.
    Tsao YT; Huang YF; Kuo CY; Lin YC; Chiang WC; Wang WK; Hsu CW; Lee CH
    Int J Mol Sci; 2016 Feb; 17(2):248. PubMed ID: 26901194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hinokitiol-induced decreases of tyrosinase and microphthalmia-associated transcription factor are mediated by the endoplasmic reticulum-associated degradation pathway in human melanoma cells.
    Oyama T; Ogawa H; Shirai Y; Abe H; Kamiya T; Abe T; Tanuma SI
    Biochimie; 2022 Jan; 192():13-21. PubMed ID: 34536557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-melanogenic effects of epigallocatechin-3-gallate (EGCG), epicatechin-3-gallate (ECG) and gallocatechin-3-gallate (GCG) via down-regulation of cAMP/CREB /MITF signaling pathway in B16F10 melanoma cells.
    Zhang X; Li J; Li Y; Liu Z; Lin Y; Huang JA
    Fitoterapia; 2020 Sep; 145():104634. PubMed ID: 32454171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation.
    Kim DS; Hwang ES; Lee JE; Kim SY; Kwon SB; Park KC
    J Cell Sci; 2003 May; 116(Pt 9):1699-706. PubMed ID: 12665551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation.
    Kim DS; Park SH; Park KC
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1482-91. PubMed ID: 15147727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terrein: a new melanogenesis inhibitor and its mechanism.
    Park SH; Kim DS; Kim WG; Ryoo IJ; Lee DH; Huh CH; Youn SW; Yoo ID; Park KC
    Cell Mol Life Sci; 2004 Nov; 61(22):2878-85. PubMed ID: 15558216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes.
    Kim DS; Kim SY; Chung JH; Kim KH; Eun HC; Park KC
    Cell Signal; 2002 Sep; 14(9):779-85. PubMed ID: 12034359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lysophosphatidic acid on melanogenesis.
    Kim DS; Park SH; Kwon SB; Youn SW; Park KC
    Chem Phys Lipids; 2004 Feb; 127(2):199-206. PubMed ID: 14726002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-melanogenic activity of phytosphingosine via the modulation of the microphthalmia-associated transcription factor signaling pathway.
    Jang EJ; Shin Y; Park HJ; Kim D; Jung C; Hong JY; Kim S; Lee SK
    J Dermatol Sci; 2017 Jul; 87(1):19-28. PubMed ID: 28390782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of hinokitiol on tyrosinase activity and melanin biosynthesis and its antimicrobial activities.
    Zhu YJ; Qiu L; Zhou JJ; Guo HY; Hu YH; Li ZC; Wang Q; Chen QX; Liu B
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):798-803. PubMed ID: 20578978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geranylgeranylacetone inhibits melanin synthesis via ERK activation in Mel-Ab cells.
    Kim EH; Jeong HS; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
    Life Sci; 2013 Aug; 93(5-6):226-32. PubMed ID: 23792203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfanyl peptide decreases melanin synthesis via receptor-mediated ERK activation and the subsequent downregulation of MITF and tyrosinase.
    Choi HR; Kang YA; Lee HS; Park KC
    Int J Cosmet Sci; 2016 Jun; 38(3):279-85. PubMed ID: 26518989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes.
    Kim DS; Park SH; Kwon SB; Park ES; Huh CH; Youn SW; Park KC
    Pigment Cell Res; 2006 Apr; 19(2):146-53. PubMed ID: 16524430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of N,N,N-trimethyl phytosphingosine-iodide on melanogenesis via ERK activation-mediated MITF degradation.
    Lee WJ; Bang S; Chung BY; Jung H; Oh ES; Chang SE
    Biosci Biotechnol Biochem; 2016; 80(1):121-7. PubMed ID: 26263195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin-induced Akt activation decreases melanogenesis through downregulation of microphthalmia-associated transcription factor and tyrosinase.
    Jeong HS; Gu GE; Jo AR; Bang JS; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
    Eur J Pharmacol; 2015 Aug; 761():19-27. PubMed ID: 25934572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
    Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
    Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid inhibits melanogenesis by activating the autophagy system in cultured melanoma cells.
    Cho YH; Park JE; Lim DS; Lee JS
    J Dermatol Sci; 2017 Oct; 88(1):96-102. PubMed ID: 28669590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 523.